Labcorp (NYSE:LH) announced today that it launched an at-home collection kit that measures HbA1c from a small blood sample. Burlington, North Carolina-based Labcorp’s first-of-its-kind diagnostic offering uses a collection device from Weavr Health and is offered through its Labcorp OnDemand platform. The company said in a news release that it’s the only commercial laboratory to […]
LabCorp
LabCorp completes $1.2B Chiltern buy
Diagnostics company LabCorp (NYSE:LH) said today that it has closed its $1.2 billion acquisition of contract research organization Chiltern International. Chiltern is slated to fold into the company’s Covance drug development business, which conducts clinical trials for drugmakers. “The addition of Chiltern advances a key element of LabCorp’s strategy – to bring innovative medicines to patients […]
Emulate, LabCorp’s Covance launch organ-on-a-chip program
Emulate, Inc. and LabCorp‘s (NYSE:LH) Covance Drug Development biz inked a deal to collaborate for an organ-on-a-chip preclinical drug evaluation and testing service. Emulate’s organ-on-a-chip tech is designed to be a predictive model of the human body’s response to diseases and medications. The companies plan to combine the organ modeling tech with Covance’s expertise of […]
